These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 15558532

  • 1. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
    Pea F, Viale P, Lugano M, Pavan F, Scudeller L, Della Rocca G, Furlanut M.
    Am J Kidney Dis; 2004 Dec; 44(6):1097-102. PubMed ID: 15558532
    [Abstract] [Full Text] [Related]

  • 2. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
    Meyer B, Kornek GV, Nikfardjam M, Karth GD, Heinz G, Locker GJ, Jaeger W, Thalhammer F.
    J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
    [Abstract] [Full Text] [Related]

  • 3. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Picetti E, Sagripanti S, Manini P, Andreoli R, Cabassi A.
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [Abstract] [Full Text] [Related]

  • 4. Clearance of linezolid via continuous venovenous hemodiafiltration.
    Mauro LS, Peloquin CA, Schmude K, Assaly R, Malhotra D.
    Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
    [Abstract] [Full Text] [Related]

  • 5. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
    Kraft MD, Pasko DA, DePestel DD, Ellis JJ, Peloquin CA, Mueller BA.
    Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
    [Abstract] [Full Text] [Related]

  • 6. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK, Foudraine NA, Burgers DM, Neef K, le Noble JL.
    Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
    [Abstract] [Full Text] [Related]

  • 7. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
    Cirillo I, Vaccaro N, Balis D, Redman R, Matzke GR.
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1187-93. PubMed ID: 21199922
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
    Guenter SG, Iven H, Boos C, Bruch HP, Muhl E.
    Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL, de Jongh J, Zuideveld KP, Danhof M, Thijs LG, Strack van Schijndel RJ.
    Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J, Krouzecky A, Stehlik P, Sykora R, Chvojka J, Karvunidis T, Novak I, Matejovic M.
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [Abstract] [Full Text] [Related]

  • 11. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
    Bellmann R, Egger P, Gritsch W, Bellmann-Weiler R, Joannidis M, Dunzendorfer S, Wiedermann CJ.
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.
    Van Matre ET, Mueller SW, Fish DN, MacLaren R, Cava LF, Neumann RT, Kiser TH.
    Am J Case Rep; 2017 Apr 27; 18():458-462. PubMed ID: 28446744
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
    Kiser TH, Fish DN, Aquilante CL, Rower JE, Wempe MF, MacLaren R, Teitelbaum I.
    Crit Care; 2015 Feb 03; 19(1):32. PubMed ID: 25645660
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and Pharmacodynamics of Linezolid in Patients With Sepsis Receiving Continuous Venovenous Hemofiltration and Extended Daily Hemofiltration.
    Zheng J, Sun Z, Sun L, Zhang X, Hou G, Han Q, Li X, Liu G, Gao Y, Ye M, Wang H, Yu K.
    J Infect Dis; 2020 Mar 16; 221(Suppl 2):S279-S287. PubMed ID: 32176792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, Harger NJ, Foertsch MJ, Winter JB, Carter KE, Van Fleet SL, Athota K, Mueller EW.
    Pharmacotherapy; 2019 Nov 16; 39(11):1066-1076. PubMed ID: 31549737
    [Abstract] [Full Text] [Related]

  • 20. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, Winnock S, Montaudon D, Bedry R, Nouts C, Pillet O, Benissan GG, Favarel-Guarrigues JC, Castaing Y.
    Crit Care; 2003 Dec 16; 7(6):R160-6. PubMed ID: 14624691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.